Micron Technology
MU
Intel
INTC
Qualcomm
QCOM
Disney
DIS
Cisco
CSCO
US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.654
- +0.004+0.66%
Close Jan 7 16:00 ET
- 0.650
- -0.004-0.64%
Post 20:01 ET
167.42MMarket Cap-3.92P/E (TTM)
0.670High0.600Low2.14MVolume0.660Open0.650Pre Close1.37MTurnover1.23%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High2.09P/B113.76MFloat Cap0.53252wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM10.77%Amplitude0.420Historical Low0.638Avg Price1Lot Size
Adaptimmune Therapeutics News
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(14.73%),David E. Goel(14.73%)
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Menzel Garry E
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Alleva Lawrence M
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Furey John
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hegde Priti
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hege Kristen
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Allen Andrew R
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia
Adaptimmune Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%), etc.
Adaptimmune Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner EcoR1 Capital, LLC
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%), etc.
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%), etc.
Adaptimmune Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%), etc.
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.01%)
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rawcliffe Adrian
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
